Protara Therapeutics, Inc. (TARA) is a clinical-stage biopharmaceutical company based in New York, focused on advancing innovative therapies for cancer and rare diseases. The company is committed to addressing significant unmet medical needs by developing its proprietary product candidates, which leverage advanced drug delivery technologies to enhance therapeutic efficacy. With a robust pipeline and strategic partnerships, Protara aims to bring transformative treatments to patients while maximizing shareholder value.